Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-02-05 @ 3:01 PM
Study NCT ID:
NCT05936359
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2023-06-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Sponsor:
Incyte Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myeloproliferative Neoplasms | View |